NEWS

Times of India - Concept Medical
From India to World: How Concept Medical is Rewriting the Global Medtech Narrative
nejm-logo
Sirolimus-Coated Balloon Angioplasty for Infrainguinal Artery Disease
Concept Medical announces enrollment of first patient in ‘’Magical-ISR’’ IDE study in the US
Concept Medical (MagicTouch PTA 0.035 OTW) receives CE Mark for treatment of peripheral artery disease.

AWARDS

Best-Workplaces-for-Women-in-2026
Concept Medical Group recognized among India’s Top 100 Best Workplaces for Women 2026
23/09/2026
Great Place to Work
Concept Medical Group is proud to be Great Place to Work® Certified for the second consecutive year, and once again recognized among India’s Great Mid-Size Workplaces™ 2026.
24/06/2026
Concept Medical Group recognized among India’s top 30 mid-size best workplaces in manufacturing 2026
Concept Medical Group recognized among India’s top 30 mid-size best workplaces in manufacturing 2026
30/01/2026

PRESS RELEASE

03/11/2026
SIRONA 3-Year Results: Sirolimus-Coated Balloon Shows Higher Freedom From Repeat Revascularization Than Paclitaxel-Coated Balloons in Femoropopliteal Disease
01/11/2026
Late-breaking results presented at TCT 2026 show an implant-free strategy with MagicTouch Sirolimus Coated Balloon is non-inferior to everolimus-eluting stents in de novo coronary artery disease
18/09/2026
SirPAD Subgroup Study at VIVA 2026 Focuses on Femoropopliteal PAD in Patients With Claudication
30/03/2026
SirPAD: Primary Results confirm the safety and efficacy of Sirolimus Coated Balloon in PAD